High expression of FOXM1 in breast cancer is associated with larger tumor size, lymphovascular invasion, lymph node metastasis, aggressive phenotype, resistance to chemotherapy, and an overall poor prognosis (Saba et al., 2016; Vishnubalaji and Alajez, 2021). This evidence concerns the gene FOXM1 and breast carcinoma.